Cat. No.: X23-10-ZQ174
RIP kinase inhibitor GSK2982772, Purity ≥98%
Synonym: 1622848-92-3; GSK2982772; GSK-2982772; (S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-3-carboxamide; (S)-3-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-5-carboxamide; RIP kinase inhibitor
- MDL: MFCD30828708
- CAS Number: 1622848-92-3
- Compound CID: 77108121
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Properties
Description
GSK2982772, soluble in DMSO and ethanol and insoluble in water, is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.
Molecular Formula
C20H19N5O3
Solubility
DMSO: 66 mg/mL (174.87 mM); Water: Insoluble; Ethanol: 26 mg/mL (68.89 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
GSK2982772 can be studied for its potential to inhibit RIPK1 in inflammatory and autoimmune disease research.
Related Products
